32
Participants
Start Date
January 17, 2022
Primary Completion Date
February 10, 2022
Study Completion Date
May 20, 2023
Compared the trombogenicity of the Solacea dialyzer with synthetic dialyzers after progressively decreasing heparin until discontinuing it
The duration of the study was four weeks, carried out in two phases. After screening, patients were randomized to be dialyzed with the Solacea™ hemodialyzer versus the usual hemodialyzer, which in all cases had to be a synthetic membrane. In both arms, heparin was progressively decreased until it was discontinued. Afterwards the patients were crossed over to the other arm.
Hospital Universitario Infanta Leonor, Madrid
Fundación Senefro
OTHER